The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism-Reference-Cited by-同舟云学术

The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism

Published:2008-06-05 Issue:10 Volume:149 Page:4780-4793
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Angelone Tommaso¹²,Quintieri Anna Maria¹,Brar Bhawanjit K.³,Limchaiyawat Pauline T.³,Tota Bruno¹,Mahata Sushil K.³,Cerra Maria Carmela¹²

Affiliation:

1. Departments of Cell Biology (T.A., A.M.Q., B.T., M.C.C.)

2. Pharmaco-Biology (T.A., M.C.C.), University of Calabria, Arcavacata di Rende 87030, Italy

3. Department of Medicine (B.K.B., P.T.L., S.K.M.), University of California and Veterans Affairs San Diego Healthcare System, San Diego, California 92093-0838

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/149/10/4780/8991686/endo4780.pdf

Reference56 articles.

1. The chromogranins A and B: the first 25 years and future perspectives.;Winkler;Neuroscience,1992

2. Mechanisms of disease: the chromogranin-secretogranin family.;Taupenot;N Engl J Med,2003

3. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.;Helle;Cell Mol Life Sci,2007

4. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.;Tatemoto;Nature,1986

5. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments.;Aardal;J Neuroendocrinol,1993

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Catestatin in Preeclampsia;International Journal of Molecular Sciences;2024-02-20

2. Mitochondrial-derived peptides: Antidiabetic functions and evolutionary perspectives;Peptides;2024-02

3. Cardiokines and cardiac remodeling;Cellular, Molecular, and Environmental Contribution in Cardiac Remodeling;2024

4. Low catestatin as a risk factor for cardiovascular disease – assessment in patients with adrenal incidentalomas;Frontiers in Endocrinology;2023-07-14

5. Catestatin Protects Against Diastolic Dysfunction by Attenuating Mitochondrial Reactive Oxygen Species Generation;Journal of the American Heart Association;2023-05-02